NCT01702194View on ClinicalTrials.gov

TD-1211 IV/Oral Mass Balance Study

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

February 28, 2013

Study Completion Date

March 31, 2013

Conditions
OIC
Interventions
DRUG

TD-1211 IV [C14]

DRUG

TD-1211 PO [C14]

Trial Locations (1)

53704

Covance, Madison

Sponsors
All Listed Sponsors
lead

Theravance Biopharma

INDUSTRY